Ignite Creation Date:
2024-05-06 @ 2:16 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT02001389
Status:
COMPLETED
Last Update Posted:
2014-10-10
First Post:
2013-11-27
Brief Title:
Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of 18FMNI-659 by EVP-6308
Sponsor:
FORUM Pharmaceuticals Inc
Organization:
FORUM Pharmaceuticals Inc
Study Overview
Official Title:
A Phase 1 Open-Label Multiple Ascending Dose 18FMNI-659 PET-Imaging Study to Evaluate PDE10A Occupancy After Dosing With EVP-6308 in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label single-arm multiple ascending dose Phase I study to assess the dose- and concentration-dependent displacement of 18FMNI-659 a PET tracer targeting phosphodiesterase 10 PDE10 by EVP-6308
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None